2. Search Result
Search Result
Results for "

lepidota

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

5

Peptides

2

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N0914
    Ajugol
    2 Publications Verification

    		 Parasite Others
    Ajugol is an iridoid glycoside that can be isolated from Leonurus artemisia. Ajugol has anti-protozoal activity againt Trypanosoma b. rhodesiense with an IC50 of 31.8 μg/mL .
    Ajugol
  • HY-N11115
    Macedonoside A

    		Others Others
    Macedonoside A (compound 3) is a kind of saponin. Macedonoside A can be isolated from the stolons of Glycyrrhiza lepidota .
    Macedonoside A
  • HY-N3947
    Glepidotin B

    		Bacterial Infection
    Glepidotin B is a dihydroflavonol compound isolated from the extracts of American licorice, Glycyrrhiza lepidota (Leguminosae). Glepidotin B is an antimicrobial agent .
    Glepidotin B
  • HY-P10307
    DOTA-ubiquicidin (29–41)

    		Bacterial Infection
    DOTA-ubiquicidin (29-41), an antimicrobial peptide fragment derivative, can be used for synthesis of [ 68Ga]Ga-DOTA-Ubiquicidin29-41 and then used for imaging of infectious processes using PET/CT .
    <em>DOTA</em>-ubiquicidin (29–41)
  • HY-P10131
    3BP-3940

    		FAP Cancer
    3BP-3940 is a highly potent fibroblast activation protein (FAP)-targeting peptide for theranostics. 3BP-3940 is often coupled with radionuclides for tumor diagnosis and treatment .
    3BP-3940
  • HY-P5297
    DOTA-CXCR4-L

    		CXCR Cancer
    DOTA-CXCR4-L is a CXCR4 targeting peptide. DOTA-CXCR4-L can be used in the study of cancers, including glioblastoma and triple-negative breast cancer .
    <em>DOTA</em>-CXCR4-L
  • HY-P10444
    DOTA Conjugated JM#21 derivative 7

    		CXCR Cancer
    DOTA Conjugated JM#21 derivative 7 (compound Ligand-7) is a derivative of CXCR4 targeting peptide conjugated with DOTA and can be used to produce radioligands. Radiolabeled DOTA Conjugated JM#21 derivative 7, i.e., 177Lu-DOTA, has excellent CXCR4 tumor targeting. In vitro biodistribution results of 177Lu-DOTA showed very low uptake in all non-targeted organs except kidney .
    <em>DOTA</em> Conjugated JM#21 derivative 7
  • HY-P10273
    DOTA-Octreotide

    		Biochemical Assay Reagents Cancer
    DOTA-Octreotide is composed of chelator DOTA and Octreotide (HY-P0036). DOTA-Octreotide is utilized for diagnosis and therapy of cancer, through combination with radioactive elements .
    <em>DOTA</em>-Octreotide

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: